Roche
HealthcareFounded in 1896 in Basel, Switzerland by Fritz Hoffmann-La Roche, Roche is the world's largest biotech company and a global leader in in-vitro diagnostics and personalized healthcare.
Official Roche Careers Website
Quick Facts
- Founded
- 1896
- Founder
- Fritz Hoffmann-La Roche
- Headquarters
- Basel, Switzerland
- Public Ticker
- SIX: ROG / ROG.S
About Roche
F. Hoffmann-La Roche & Co. was founded in 1896 in Basel, Switzerland by Fritz Hoffmann-La Roche as a manufacturer of standardized pharmaceutical preparations. It pioneered industrial vitamin production and synthetic pharmaceuticals.
Today, Roche is the world's largest biotechnology company and the global leader in in-vitro diagnostics, generating over 58 billion Swiss Francs ($65B+ USD) annually. Combining pharmaceuticals (Genentech, Chugai) and diagnostics, Roche advances personalized healthcare, targeted cancer treatments, neurology (Ocrevus, Evrysdi), ophthalmology (Vabysmo), and automated lab diagnostic instruments.
What Roche Does
Biopharmaceuticals & Genentech
Targeted cancer immunotherapies, monoclonal antibodies, neuroscience, and ophthalmology.
Roche Diagnostics
In-vitro diagnostic instruments, molecular diagnostics, tissue pathology, and diabetes management.
Personalized Healthcare (PHC)
Combining genomic profiling, clinical data analytics, and targeted medicines for individualized treatment.
Pathology & Digital Solutions
AI-assisted digital pathology, slide scanners, and automated laboratory workflows.
Career Areas
Types of professional roles found inside Roche.
- Biotech Science & Translational Medicine
- Diagnostic Instrument Engineering & Software
- Data Science & Bioinformatics
- Clinical Operations & Medical Affairs
- Global Supply Chain & Quality Assurance
- Commercial Strategy & Access
- Finance & Accounting
- People & Culture Operations
Roche's History
- 1896Founded in Basel
Fritz Hoffmann-La Roche founds F. Hoffmann-La Roche & Co. in Basel, Switzerland.
- 1990Genentech Majority Stake
Acquires majority stake in biotech pioneer Genentech, acquiring full ownership in 2009.
- 2018Flatiron Health Acquisition
Acquires oncology health tech platform Flatiron Health for $1.9 billion.
- 2020COVID-19 Diagnostic Deployment
Deploys high-throughput automated PCR testing systems globally during the pandemic.
- 2023Telavant Acquisition
Acquires Telavant for $7.1 billion to gain promising Phase 3 inflammatory bowel disease therapy.
Purpose & Values
โDoing now what patients need nextโ